Sale!

TYR Gene Albinism Oculocutaneous Type 1A Genetic Test

Name: TYR Gene Albinism Oculocutaneous Type 1A Genetic Test
SKU: TEST-909
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TYR Gene Albinism Oculocutaneous Type 1A Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the TYR gene that are responsible for Oculocutaneous Albinism Type 1A (OCA1A). OCA1A is a rare genetic disorder characterized by a lack of melanin, the pigment that colors the skin, hair, and eyes, leading to visual problems and increased susceptibility to skin damage from sunlight. This specific test plays a crucial role in confirming the diagnosis of OCA1A, enabling healthcare providers to offer appropriate genetic counseling and manage the condition effectively. The test is priced at 4400 AED and involves analyzing the individual’s DNA to detect the presence of mutations in the TYR gene, providing valuable insights for affected individuals and their families regarding the condition.

Description

TYR Gene Albinism oculocutaneous type 1A Genetic Test

At DNA Labs UAE, we offer the TYR Gene Albinism oculocutaneous type 1A Genetic Test for AED 4400.0.

Test Name: TYR Gene Albinism oculocutaneous type 1A Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ophthalmology Disorders

Doctor: Ophthalmologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TYR Gene Albinism, oculocutaneous type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TYR Gene Albinism, oculocutaneous type 1A NGS Genetic DNA Test gene TYR

Test Details:

The TYR gene is responsible for producing an enzyme called tyrosinase, which plays a critical role in the production of melanin pigment in the skin, hair, and eyes. Mutations in the TYR gene can lead to a condition called oculocutaneous albinism type 1A, which is characterized by a lack of melanin pigment in the skin, hair, and eyes.

NGS (next-generation sequencing) genetic testing is a type of genetic testing that uses advanced technology to rapidly sequence large amounts of DNA. This allows for the detection of mutations in the TYR gene and other genes associated with oculocutaneous albinism type 1A with high accuracy and efficiency.

NGS genetic testing for oculocutaneous albinism type 1A can help diagnose the condition and provide information about the specific genetic mutations that are causing it. This information can be used to develop personalized treatment plans and to provide genetic counseling to affected individuals and their families.

Test Name	TYR Gene Albinism oculocutaneous type 1A Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ophthalmology Disorders
Doctor	Ophthalmologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for TYR Gene Albinism, oculocutaneous type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TYR Gene Albinism, oculocutaneous type 1A NGS Genetic DNA Test gene TYR
Test Details	The TYR gene is responsible for producing an enzyme called tyrosinase, which plays a critical role in the production of melanin pigment in the skin, hair, and eyes. Mutations in the TYR gene can lead to a condition called oculocutaneous albinism type 1A, which is characterized by a lack of melanin pigment in the skin, hair, and eyes. NGS (next-generation sequencing) genetic testing is a type of genetic testing that uses advanced technology to rapidly sequence large amounts of DNA. This allows for the detection of mutations in the TYR gene and other genes associated with oculocutaneous albinism type 1A with high accuracy and efficiency. NGS genetic testing for oculocutaneous albinism type 1A can help diagnose the condition and provide information about the specific genetic mutations that are causing it. This information can be used to develop personalized treatment plans and to provide genetic counseling to affected individuals and their families.